To examine whether altered gene expression of insulin receptor substrates (IRS)-1 and IRS-2 and Src homologous and collagen-like protein Shc is an inherited trait and is associated with muscle insulin resistance or type 2 diabetes, we measured mRNA levels of these genes by a relative quantitative RT-PCR method in muscle biopsies taken before and after an insulin clamp from 12 monozygotic twin pairs discordant for type 2 diabetes and 12 control subjects. Insulin-stimulated glucose uptake was decreased both in the diabetic and nondiabetic twin, compared with healthy control subjects ( 
I
NSULIN BINDS TO and activates the insulin receptor kinase, which, in turn, phosphorylates insulin receptor substrates (IRSs). The major substrates of the insulin receptor are IRS-1, IRS-2, and Src homologous and collagen-like protein Shc (1) (2) (3) , which are expressed in various tissues, including skeletal muscle. Upon phosphorylation, these substrates act as docking proteins for downstream complexes, leading to downstream mitogenic and metabolic effects, including insulin-mediated glucose uptake. Both IRS-1 and IRS-2 are necessary for insulin-stimulated Glut4 translocation via PI 3-kinase pathway in adipocytes and in skeletal muscle (1, 4, 5) . Also, IRS-1 and Shc can interact with Son-of-sevenless/Grb-2 complex and thus activate the Ras/MAPK pathway. The Ras/MAPK pathway has also been shown to enhance membrane Glut 4 intrinsic activity in adipose cells and L6 myotubes (6) . To date, no consistent mutations have been found in IRS-2 and Shc genes responsible for muscle insulin resistance in type 2 diabetes, apart from a polymorphism in the IRS-1 gene implicated in ␤-cell dysfunction (7) (8) (9) . Insulin has been ascribed a regulatory effect on the expression of some genes involved in insulin action and glucose metabolism in human skeletal muscle, including up-regulation of PI 3-kinase, Glut4, hexokinase II, Rad, and glycogen synthase (10 -14) , and down-regulation of lipoprotein lipase (10) . Altered gene expression of hexokinase II, PI 3-kinase, and glycogen synthase has been reported in muscle of type 2 diabetic patients (12) (13) (14) (15) . Little is known about whether altered IRS-1, IRS-2, and Shc gene expression is an inherited trait or associated with muscle insulin resistance or type 2 diabetes. To address this question, we analyzed IRS-1, IRS-2, and Shc gene expression in muscle biopsies taken before and after an insulin clamp from 12 control subjects and from 12 monozygotic twins pairs discordant for type 2 diabetes (16, 17) . The study of monozygotic twins discordant for diabetes allowed us to study whether the potential defect of gene expression is under genetic control.
Subjects and Methods Subjects
Twelve Caucasian monozygotic twin pairs discordant for type 2 diabetes and 12 healthy subjects without family history of diabetes participated in the study. Type 2 diabetes had been diagnosed after the age of 40 yr, based on a standardized 75-g oral glucose tolerance test (18) . The control subjects were matched to the nondiabetic twins for age, sex, and body mass index (Table 1) . Monozygosity of the twins was confirmed by genetic markers (16) . Insulin sensitivity was measured by a 3-h euglycemic hyperinsulinemic clamp with prior infusion of insulin (16, 17) . Muscle biopsies were obtained in the basal state (0 min) and at Abbreviations: FFM, Fat free mass; IRS, insulin receptor substrate; M-value, insulin-mediated glucose uptake; RT, reverse transcriptase; Shc, Src homologous and collagen-like protein.
the end of the clamp (ϩ180 min), frozen immediately in liquid nitrogen, and stored at Ϫ80 C until analyzed. Informed consent was obtained from all subjects. The protocol was approved by the regional ethics committee, and the study was conducted according to the principles of the Declaration of Helsinki.
Quantitation of IRS-1, IRS-2, and SHC gene expression
RNA expression was examined using a modified primer-dropping RT-PCR method (19) . Total RNA was isolated from the muscle biopsies by the acid guanidinium thiocyanate method (20) and was subjected to DNase I (Promega Corp., Madison, WI) treatment, according to the manufacturer's instruction, to avoid genomic DNA contamination. The treated total RNA (400 ng) was then reverse-transcribed in a 40-l reaction with a 5-m oligo(dT) 18 primer in the presence of 200 U SUPERSCRIPT II reverse transcriptase (RT) (Life Technologies, Inc., Glasgow, Scotland) and 25 m deoxynucleotide triphosphate for 60 min at 37 C. After heat inactivation of the RT at 95 C for 5 min, total cDNA was subjected to PCR coamplification of IRS-1, IRS-2, Shc genes, together with cyclophilin as a reference gene. Cyclophilin was used as a reference gene because it is unaffected by insulin and the diabetic state (21) . Validation of this method has been described in a previous study (11) . The primer pairs for IRS-1 were (from 5Ј to 3Ј) CTTCTGTCAGGTGTC-CATCC and CTCTGCAGCAATGCCTGTTC; for IRS-2, ACAATGGT-GACTACACCGAG and CTGCTTTTCCTGAGAGAGAC; and for Shc, GGGACCTGTTTGACATGAAG and TAGGGAATAGGGTGGAAAGG. The Shc primers define a region that is included in all the 3 Shc isoforms p66, p52, and p46. The primer pairs for cyclophilin (cycloF-cycloR or cycloF-cycloR2) were: GTCTCCTTTGAGCTGTTTGC (cycloF), TGGC-CTCCACAATATTCATGC (cycloR), CTGGGAACCATTTGTGTTGG (cycloR2). To study the effect of insulin on gene expression, we measured IRS-1, IRS-2, and Shc mRNA levels in skeletal muscle biopsies from 12 control subjects, before and after a euglycemic clamp, using the following conditions: For IRS-1, the PCR reaction (20 l) contains 2 l RT reaction, 1ϫ PCR buffer, 200 m deoxynucleotide triphosphate, 5% dimethylsulfoxide, 5% formamide, 0.5 U Taq polymerase, 0.25 m IRS-1 primers, and 0.2 m cyclophilin primers (cycloF-cycloR2). The PCR was run for 36 cycles (94 C, 30 sec; 55 C, 30 sec; 72 C, 30 sec) and followed by a final extension at 72 C for 10 min. For IRS-2 and Shc, the PCR conditions were similar to that of IRS-1 except for cycle numbers and primer concentrations (44 for 0.25 m IRS-2 primers, 40 for 0.2 m cycloF-cycloR2; 34 for 0.2 m Shc primers, 34 for 0.2 m cycloF-cycloR). The PCR conditions were optimized according to the primer-dropping method (19) for each individual gene. PCR products were separated on a 2% agarose gel containing ethidium bromide, photographed with UPP-110HA printing paper (Sony, Tokyo, Japan), and quantitated using a Personal Densitometer SI scanner together with ImageQuant software (Molecular Dynamics, Inc., Sunnyvale, CA). The mRNA signals were expressed relative to that of cyclophilin. To examine whether altered gene expression of IRS-1, IRS-2, and Shc is associated with type 2 diabetes, we measured basal and postclamp mRNA concentrations of these genes in all three groups (Table 1) . We used the same conditions as described above for measuring basal IRS-1, IRS-2, and Shc mRNA concentrations. Postclamp Shc mRNA concentrations were also measured under the same conditions as above, but postclamp IRS-1 and IRS-2 mRNA concentrations were measured using different conditions. This was because the IRS-1 and IRS-2 mRNA concentrations in some postclamp samples were too low to measure using the conditions described above. To measure such low mRNA concentrations and to allow a direct comparison of them among the groups, we had to change the conditions for postclamp IRS-1 and IRS-2 concentration measurements.
Analytical measurements
Plasma glucose was determined with a glucose oxidase method (Glucose Analyzer 2; Beckman Coulter, Inc. Instruments, Fullerton, CA). Plasma insulin was measured using a double-antibody RIA (Pharmacia Diagnostics, Uppsala, Sweden) (16, 17) .
Statistical analysis
Data are expressed as means Ϯ sem. Statistical analysis was performed using an NCSS 6.0.21 statistical package (NCSS Statistical Software, Kaysville, UT). The significance of differences within or between groups was tested by Wilcoxon or Mann-Whitney rank tests. The relationship between various variables was analyzed by Spearman correlations.
Results

Clinical characteristics of the subjects
Fasting plasma glucose levels were higher in both the diabetic and the nondiabetic twins, whereas fasting plasma insulin levels were higher only in diabetic twins, compared with those of the control subjects (Table 1) . Plasma insulin concentrations in the basal state and during the clamp were similar in the diabetic (69.6 Ϯ 16.5 and 528.1 Ϯ 51.6 pm) and the nondiabetic (50.9 Ϯ 6.4 and 497.9 Ϯ 40.9 pm) twins as well as in the control subjects (45.9 Ϯ 5.0 and 559.6 Ϯ 32.3 pm). The diabetic twins had 55% lower rates of insulin-stimulated glucose uptake (P Ͻ 0.01), 63% lower rates of glucose storage (P Ͻ 0.01), and 37% lower rates of glucose oxidation (P Ͻ 0.01), compared with the control subjects ( Table 1 ). The nondiabetic monozygotic co-twins also had a 25% lower rate of insulin-stimulated glucose uptake [8.5 Ϯ 0.8 vs. 11.4 Ϯ 0.9 mg/kg fat free mass (FFM) per min; P Ͻ 0.03], which was particularly caused by a 37% decrease in the rate of glucose storage (4.8 Ϯ 0.6 vs. 7.6 Ϯ 0.9 mg/kg FFM per min; P Ͻ 0.02), compared with the control subjects ( Table 1) .
IRS-1, IRS-2, and Shc gene expression
Basal IRS-1, IRS-2, and Shc mRNA levels were similar in the diabetic and nondiabetic twins as well as in the control subjects (Table 2) . Insulin infusion decreased IRS-1 mRNA (Fig. 1 ). The postclamp Shc mRNA level was slightly higher in the diabetic twins (P ϭ 0.05) but similar in the nondiabetic twins, as compared with the control subjects ( Table 2) , whereas postclamp IRS-1, IRS-2 mRNA levels were similar in all three groups (Table 2 ). There was an inverse correlation between the postclamp Shc mRNA concentration and the insulin-mediated glucose uptake (M-value) in all subjects (r ϭ Ϫ0.52, P Ͻ 0.01). This correlation was also observed in the combined group of the control subjects and the nondiabetic twins (r ϭ Ϫ0.53, P ϭ 0.01), whereas no correlation was observed between the basal Shc mRNA concentration and the M-value. However, the change in Shc gene expression between basal and postclamp states was not significantly different among the three groups.
Neither basal nor postclamp IRS-1 and IRS-2 mRNA concentrations showed any significant correlation with the Mvalues, either in all subjects or in the subgroups (data not shown).
Discussion
In this study, we examined the gene expression of three substrates of the insulin receptor kinase, i.e. IRS-1, IRS-2, and Shc, in skeletal muscle from monozygotic twins discordant for diabetes and healthy control subjects. Whereas insulin clearly decreased expression of these substrates, no difference was seen between diabetic and control subjects, nor between diabetic and nondiabetic twins. It is well established that insulin stimulates phosphorylation of IRS-1, IRS-2, and Shc through binding to and activation of the insulin receptor kinase, thereby activating downstream effectors. Phosphorylation occurs rapidly, within a few minutes after insulin stimulation. However, after prolonged insulin treatment, desensitization to insulin action occurs at multiple steps, including both protein and mRNA changes. Insulin-induced receptor down-regulation, as reflected by a decrease in insulin binding, has been reported in murine NIH 3T3 HIR3.5 fibroblasts (22) . In this cell model, the decrease in insulin binding is associated with decreased cellular insulin receptor content (22) . In rat AR42J pancreatic acinar cells (23) and in human HepG2 hepatocytes (24) , the decrease in the insulin receptor protein concentration could be, at least in part, attributed to decreased insulin receptor mRNA concentration. However, in rat hepatoma cells, insulin down-regulation of the receptor may not be sufficient to completely account for insulin desensitization (25) . Therefore, a down-regulation of postreceptor substrates has been proposed (25) and demonstrated in rat hepatoma cells (26) . Song et al. (27) showed that IRS-1 and IRS-2 phosphorylation was initially increased and subsequently decreased, in a time-dependent manner, in three types of rat skeletal muscles incubated with insulin for (29), and Sprague Dawley rats fed with high-fat diet (30) . In addition, a recent study by Shimomura et al. (31) reported that chronic hyperinsulinemia also reduces the amount of IRS-2 mRNA and protein in mouse liver, both in vivo and in vitro. No data are, to our knowledge, available on the effect of insulin on Shc gene expression in human skeletal muscle. Together, the data clearly show that insulin downregulates gene expression of IRSs in skeletal muscle. If this down-regulation is associated with a similar reduction in protein levels, this could, of course, present a mechanism by which insulin signaling is down-regulated, providing that phosphorylation of these substrates also is impaired by insulin. Given the recent identification of calpain 10 as a putative candidate gene for type 2 diabetes (32), it is interesting to note that calpains have been ascribed a role in insulinmediated breakdown of the IRS protein (33) . The mechanism by which insulin decreases IRS mRNA concentrations is unknown. Recently, it has been demonstrated that the PKC isoform, PKC-␦, positively regulates IRS-1 gene transcription in human breast cancer cells (34) . It has also been shown that insulin causes translocation of PKC-␦ from the cytosol to the cell membrane in both rat and human skeletal muscle (35, 36) . Whether insulin-mediated PKC-␦ translocation could influence transcription of IRSs in human skeletal muscle is currently unknown. It is also clear, from our results, that the capacity of insulin to down-regulate expression of the IRS-1, IRS-2, and Shc genes is not resistant to the effect of insulin. We did not find any correlation between the degree of IRS-1 and IRS-2 gene down-regulation and the M-value, either in the diabetic or in the control subjects. In contrast, the postclamp Shc gene expression was inversely correlated with the M-value, particularly in the nondiabetic subjects. It is unclear whether the slight increase in Shc mRNA concentrations seen in the diabetic twins really has a physiological meaning. Similar results were reported by Andreelli et al. (15) and Ducluzeau et al. (14) , who observed that insulin down-regulation of the IRS-1 gene was not impaired in muscle from obese and type 2 diabetic patients. Although fasting hyperinsulinemia and insulin resistance are hallmarks of IGT and mild diabetes, we did not see any impairment in the down-regulatory effect of insulin on expression of IRS-1 and IRS-2 in these subjects. One could hypothesize that chronic hyperinsulinemia could cause a reduction in mRNA expression similar to that of the insulin infusion. On the other hand, we do not know the dose-response characteristics of the effect of insulin on expression of these genes, i.e. whether fasting hyperinsulinemia in the range of 50 -80 pm is sufficient to do the same as 500 pm insulin during the clamp. Although protein levels were not examined in this study, some other studies have shown decreased levels of IRS-1 and IRS-2 proteins in muscle from obese humans (37) and insulin-resistant animals (28, 29, 38) . Moreover, chronic insulin treatment of adipocytes increased degradation of IRS-1 protein but did not change mRNA expression of IRS-1 (33, 39 -41) . In conclusion, because insulin down-regulates IRS-1, IRS-2, and Shc gene expression in skeletal muscle in the diabetic and nondiabetic monozygotic twins and the control subjects to the same extent, it is unlikely that expression of these genes is a heritable trait or contributes to skeletal muscle insulin resistance.
